Cristina Ghezzi

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol.

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol.

Journal: BMJ neurology open

Published: September 12, 2023

Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease?

Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease?

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: June 30, 2023

Effects of Circadian Phase Tailored Light Therapy on Sleep, Mood, and Cognition in Alzheimer's Disease: Preliminary Findings in a Pivotal Study.

Effects of Circadian Phase Tailored Light Therapy on Sleep, Mood, and Cognition in Alzheimer's Disease: Preliminary Findings in a Pivotal Study.

Journal: Frontiers in physiology

Published: August 08, 2021

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.

Journal: International journal of molecular sciences

Published: July 04, 2021

GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson's Disease.

GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson's Disease.

Journal: International journal of molecular sciences

Published: January 06, 2021

Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.

Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: June 08, 2020

Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease.

Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: November 27, 2018

Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity.

Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity.

Journal: Sleep medicine

Published: November 03, 2018

The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.

The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.

Journal: Frontiers in cellular neuroscience

Published: January 23, 2018

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease.

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease.

Journal: Frontiers in neuroscience

Published: April 20, 2017

Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.

Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.

Journal: Neurotoxicity research

Published: September 24, 2016

Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.

Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.

Journal: Neurogastroenterology and motility

Published: April 29, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026